Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-011189-27-IT
EUCTR2009-011189-27-IT
Active, not recruiting
Not Applicable

Phase III prospective clinical trial: 18F-FCH/PET evaluation in early diagnosis of disease recurrence in prostate cancer - FCH_PET

ISTITUTI FISIOTERAPICI OSPITALIERI0 sitesMarch 13, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ISTITUTI FISIOTERAPICI OSPITALIERI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2009
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
ISTITUTI FISIOTERAPICI OSPITALIERI

Eligibility Criteria

Inclusion Criteria

  • •Previous Treatment for prostate cancer
  • •Biochemical failure
  • •Age \> 40 years
  • •Informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Age \< 40 years
  • •Life expectancy \< 1 year

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Phase III clinical study of PET-TC with [18f]Fluoroethyilcholine ([18f]Fech) in prostate cancer: assessment of the additional role with respec to conventional imaging techniquesprostate cancerMedDRA version: 14.1Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
EUCTR2012-004297-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI750
Recruiting
Not Applicable
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant glioma
JPRN-UMIN000035976Southern TOHOKU BNCT Research Center20
Active, not recruiting
Not Applicable
A new kind of scan for patients with an overactive parathyroidon familial primary hyperparathyroidismTherapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2014-004590-16-NLMC Utrecht
Completed
Not Applicable
18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CTprimary hyperparathyroidismoverproduction Parathyroid Hormone10033949
NL-OMON40137niversitair Medisch Centrum Utrecht10
Active, not recruiting
Phase 1
Domestic Phase I/IIa Investigator-initiated Clinical Trials to Evaluate the Safety of 18F-PSMA-1007 in Healthy Adults and Subjects with Prostate Cancer
JPRN-jRCT2032210711Tateishi Ukihide13